Changqing Liu
- Molecular Biology top 10%
- Surgery top 10%
- Biomaterials top 5%
- Physiology top 10%
- Genetics
- Topics
- Epilepsy research and treatment (14 papers)Esophageal Cancer Research and Treatment (14 papers)Esophageal and GI Pathology (10 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Changqing Liu
165 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Molecular Biology 809
- Surgery 293
- Biomaterials 201
- Physiology 196
- Genetics 162
Countries citing papers authored by Changqing Liu
This map shows the geographic impact of Changqing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changqing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changqing Liu more than expected).
Fields of papers citing papers by Changqing Liu
This network shows the impact of papers produced by Changqing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changqing Liu. The network helps show where Changqing Liu may publish in the future.
Co-authorship network of co-authors of Changqing Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Changqing Liu. A scholar is included among the top collaborators of Changqing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changqing Liu. Changqing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 0 | |
| 9 | 17 | |
| 10 | 4 | |
| 11 | 19 | |
| 12 | 11 | |
| 13 | 14 | |
| 14 | 9 | |
| 15 | 7 | |
| 16 | 15 | |
| 17 | 2 | |
| 18 | 14 | |
| 19 | 18 | |
| 20 | 5 |
About Changqing Liu
Changqing Liu is a scholar working on Developmental Neuroscience, Genetics and Psychiatry and Mental health, having authored 181 papers that have together received 2.3k indexed citations. Recurring topics across this work include Epilepsy research and treatment (14 papers), Esophageal Cancer Research and Treatment (14 papers) and Esophageal and GI Pathology (10 papers). The work is most often cited by research in Biological Psychiatry (52 citations), Biomaterials (201 citations) and Molecular Medicine (74 citations). Changqing Liu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Bin Li, Yingying Liu, Meiyan Wu, Chao Liu, Yulong Sui, Youming Li, Weijun Guan, Vadim V. Silberschmidt, Hui Xu and Haibo Zhang. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.